Form 3 - Initial statement of beneficial ownership of securities

US Tech 100

20,836.00

1.31%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Ocugen Inc News

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Thursday 19 December 2024 (3 days ago) • GlobeNewswire Inc.

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
Wednesday 11 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
Wednesday 27 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
Wednesday 20 November 2024 (1 month ago) • GlobeNewswire Inc.

Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Tuesday 19 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

OCGN Ocugen Inc

Ocugen Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

OCGN Ocugen Inc

Ocugen Inc News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free